← Back to Search

Computer-based Intervention for Adolescent Alcohol Abuse (ASPIRE Trial)

N/A

Recruiting

Led By Lydia A Shrier, MD, MPH

Research Sponsored by Boston Children's Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1-12 months follow-up

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a computer system that helps pediatricians screen and give brief interventions to adolescents for unhealthy alcohol use. It is being done in over 600 primary care practices across the United States.

Who is the study for?

This trial is for teens aged 14-17 who have used alcohol in the past year or ridden with an impaired driver. They must be going for a check-up, able to complete activities before their visit, and willing to share their cell phone number. Teens already in substance use treatment, with communication barriers, or certain medical/emotional issues can't join.

What is being tested?

The study tests a computer-assisted system that helps doctors talk to teens about alcohol use and safe riding/driving practices during regular check-ups. It's part of a large trial across many U.S. clinics aiming to reduce teen alcohol abuse and improve safety on the roads.

What are the potential side effects?

Since this intervention involves counseling rather than medication, typical drug side effects are not expected. However, participants may experience discomfort discussing personal behaviors related to alcohol use.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1-12 months follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1-12 months follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-12 months follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Any heavy episodic drinking day during past 3 months

Time to first day of heavy episodic drinking during 12 month follow-up period

Secondary study objectives

Any riding/driving risk

Other study objectives

Alcohol-related problems or negative consequences experienced since post-visit survey

Drinking refusal self-efficacy

Alcohol Use Disorder

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Computer-facilitated screening and brief interventionExperimental Treatment1 Intervention

Clinicians randomized to this arm will receive training in delivery of cSBI and their participating patients will then receive the experimental intervention.

Group II: Usual CareActive Control1 Intervention

Clinicians randomized to this arm will not receive training in delivery of cSBI until study completion, and their participating patients will receive usual care.

Do I qualify?Apply below to find out